Basic Information
| RNALocate ID: | RLID-D:11000181 |
| RNA Symbol: | hsa-miR-16-2-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-16-2-3p |
| RNA ID: | miRBase:MIMAT0004518 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|Chronic lymphocytic leukemia cells|Tongue tissue |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003626 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11003627 | Exosome | Plasma | 23663360 |
| RLID:11003628 | Microvesicle | Serum | 24797360 |
| RLID-D:11000593 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-16-2-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-18657 |
| MNDR | hsa-miR-16-2-3p | Lymphoma | MNDR-E-MI-18658 |
| MNDR | hsa-miR-16-2-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-18659 |
| MNDR | hsa-miR-16-2-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-18660 |
| MNDR | hsa-miR-16-2-3p | Prostate cancer | MNDR-E-MI-18661 |
| MNDR | hsa-miR-16-2-3p | Alzheimer disease | MNDR-E-MI-18662 |
| MNDR | hsa-miR-16-2-3p | Intracranial aneurysm | MNDR-E-MI-18663 |
| MNDR | hsa-miR-16-2-3p | Esophageal carcinoma | MNDR-E-MI-18664 |
| MNDR | hsa-miR-16-2-3p | Seizures | MNDR-E-MI-18665 |
| MNDR | hsa-miR-16-2-3p | Leukemia | MNDR-E-MI-18666 |
| MNDR | hsa-miR-16-2-3p | Huntington disease | MNDR-E-MI-18667 |
| MNDR | hsa-miR-16-2-3p | Chorea | MNDR-E-MI-18668 |
| MNDR | hsa-miR-16-2-3p | Cardiovascular disease | MNDR-E-MI-18669 |
| MNDR | hsa-miR-16-2-3p | Parkinson disease | MNDR-E-MI-18670 |
| MNDR | hsa-miR-16-2-3p | Basal-like breast cancer | MNDR-E-MI-18671 |
| MNDR | hsa-miR-16-2-3p | Thyroid cancer | MNDR-E-MI-18672 |
| MNDR | hsa-miR-16-2-3p | Pancreatic cancer | MNDR-E-MI-18673 |
| MNDR | hsa-miR-16-2-3p | Rectum adenocarcinoma | MNDR-E-MI-18674 |
| MNDR | hsa-miR-16-2-3p | Colon cancer | MNDR-E-MI-18675 |
| MNDR | hsa-miR-16-2-3p | Colon adenocarcinoma | MNDR-E-MI-18676 |
| MNDR | hsa-miR-16-2-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-18677 |
| MNDR | hsa-miR-16-2-3p | Familial ovarian cancer | MNDR-E-MI-18678 |
| MNDR | hsa-miR-16-2-3p | Prostate adenocarcinoma | MNDR-E-MI-18679 |
| MNDR | hsa-miR-16-2-3p | Carcinoma ductal breast | MNDR-E-MI-18680 |
| MNDR | hsa-miR-16-2-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-18681 |
| MNDR | hsa-miR-16-2-3p | Osteosarcoma | MNDR-E-MI-18682 |
| MNDR | hsa-miR-16-2-3p | Liposarcoma | MNDR-E-MI-18683 |
| MNDR | hsa-miR-16-2-3p | Liver cancer | MNDR-E-MI-18684 |
| MNDR | hsa-miR-16-2-3p | Gastric adenocarcinoma | MNDR-E-MI-18685 |
| MNDR | hsa-miR-16-2-3p | Cervical squamous cell carcinoma | MNDR-E-MI-18686 |
| MNDR | hsa-miR-16-2-3p | Lung squamous cell carcinoma | MNDR-E-MI-18687 |
| MNDR | hsa-miR-16-2-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-18688 |
| MNDR | hsa-miR-16-2-3p | Lung adenocarcinoma | MNDR-E-MI-18689 |
| MNDR | hsa-miR-16-2-3p | Thyroid carcinoma | MNDR-E-MI-18690 |
| MNDR | hsa-miR-16-2-3p | Bladder urothelial carcinoma | MNDR-E-MI-18691 |
| MNDR | hsa-miR-16-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-18692 |
| MNDR | hsa-miR-16-2-3p | Carcinoma renal cell | MNDR-E-MI-18693 |
| MNDR | hsa-miR-16-2-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-18694 |
| MNDR | hsa-miR-16-2-3p | Renal clear cell carcinoma | MNDR-E-MI-18695 |
| MNDR | hsa-miR-16-2-3p | Cholangiocarcinoma | MNDR-E-MI-18696 |
| MNDR | hsa-miR-16-2-3p | Lung small cell carcinoma | MNDR-E-MI-18697 |
| MNDR | hsa-miR-16-2-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-18698 |
| MNDR | hsa-miR-16-2-3p | Testicular germ cell cancer | MNDR-E-MI-18699 |
| MNDR | hsa-miR-16-2-3p | Breast invasive carcinoma | MNDR-E-MI-18700 |
| MNDR | hsa-miR-16-2-3p | Hepatocellular carcinoma | MNDR-E-MI-18701 |
| MNDR | hsa-miR-16-2-3p | Familiar ovarian carcinoma | MNDR-E-MI-18702 |
| MNDR | hsa-miR-16-2-3p | Rheumatoid arthritis | MNDR-E-MI-18703 |
| MNDR | hsa-miR-16-2-3p | Malignant pleural mesothelioma | MNDR-E-MI-18704 |
| MNDR | hsa-miR-16-2-3p | Chronic fatigue syndrome | MNDR-E-MI-18705 |
| MNDR | hsa-miR-16-2-3p | Hodgkin lymphoma | MNDR-E-MI-18706 |
| MNDR | hsa-miR-16-2-3p | Neuromyelitis optica | MNDR-E-MI-18707 |
| MNDR | hsa-miR-16-2-3p | Colorectal cancer | MNDR-E-MI-18708 |
| MNDR | hsa-miR-16-2-3p | Nasopharynx carcinoma | MNDR-E-MI-18709 |
| MNDR | hsa-miR-16-2-3p | Uterine cervical neoplasms | MNDR-E-MI-18710 |
| MNDR | hsa-miR-16-2-3p | Nasopharyngeal cancer | MNDR-E-MI-18711 |
| MNDR | hsa-miR-16-2-3p | Stroke lacunar | MNDR-E-MI-18712 |
| MNDR | hsa-miR-16-2-3p | Breast cancer her3+ negative | MNDR-E-MI-18713 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | RARB | Homo sapiens | RR04232971 |
TOP